Loading…
Teleflex Incorporated is projected to rise to $171.77 by 2027, a +27% move from its current price of $135.73. TFX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $133.42 | $135.76 | $138.14 | +0.02% |
| Jul 14 | $132.49 | $135.79 | $139.17 | +0.04% |
| Jul 15 | $131.78 | $135.81 | $139.97 | +0.06% |
| Jul 16 | $131.20 | $135.84 | $140.65 | +0.08% |
| Jul 17 | $130.68 | $135.87 | $141.26 | +0.10% |
| Jul 18 | $130.23 | $135.90 | $141.81 | +0.12% |
| Jul 19 | $129.81 | $135.92 | $142.32 | +0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $129.81 | $135.92 | $142.32 | +0.14% |
| Week 2 | $127.54 | $136.12 | $145.27 | +0.28% |
| Week 3 | $125.87 | $136.31 | $147.62 | +0.43% |
| Week 4 | $124.50 | $136.50 | $149.66 | +0.57% |
| Week 5 | $123.33 | $136.70 | $151.52 | +0.71% |
| Week 6 | $122.30 | $136.89 | $153.23 | +0.86% |
| Week 7 | $121.37 | $137.09 | $154.84 | +1.00% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company serves hospitals, healthcare providers, and medical device manufacturers, and sells its products online.
Teleflex was incorporated in 1943 and is headquartered in Wayne, Pennsylvania. It offers vascular and emergency medicine products, interventional devices, and surgical instruments across brands such as Arrow, EZ-IO, QuikClot, MANTA, GuideLiner, Turnpike, TrapLiner, Arrow OnControl, and a range of surgical lines under Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS.
Teleflex Incorporated (TFX) is a healthcare company trading with a current price of $127.00 and a market capitalization of $5.62B. It ranks 1273 in market capitalization among listed assets.
The price outlook, based on the provided forecast, shows upside over the coming years. The 2026 forecast average is $127.00, and the years beyond project steadily higher averages: 2027 $164.23, 2028 $206.46, 2029 $224.22, 2030 $247.97, 2040 $564.57, and 2050 $1,266.05, with bullish sentiment from 2027 onward and substantial potential upside through 2050.
A major floor 22.3% below — a decisive break under it would weaken the trend.
The nearest floor, 10.4% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 6.9% above — clearing it would confirm fresh momentum.
Key TFX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TFX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $133.60 | Buy | $133.50 | Buy |
| MA 10 | $131.58 | Buy | $132.00 | Buy |
| MA 20 | $129.29 | Buy | $130.67 | Buy |
| MA 50 | $129.37 | Buy | $128.60 | Buy |
| MA 100 | $123.61 | Buy | $125.43 | Buy |
| MA 200 | $120.38 | Buy | $125.53 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.29 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 146.63 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.78 | Buy |
| ROC (12) | 9.23 | Buy |
| Bollinger %B (20,2) | 0.94 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.04 | Buy |
| Awesome (5,34) | 3.78 | Buy |
| Ultimate (7,14,28) | 69.63 | Neutral |
| Momentum (10) | 7.94 | Buy |
| Aroon Osc (25) | -32.00 | Sell |
| Hull MA (9) | 134.23 | Buy |
| ADX (14) | 10.45 | Neutral |
| ATR (14) | 2.29 | Info |
In the near term, the technical picture shows momentum near a neutral zone with RSI at 50 and the stock trading around key moving averages. The SMA50 is $129.33 and the SMA200 is $120.24, placing the price near the faster average but above the longer-term level.
The 30-day price range spans from a low of $113.23 to a high of $142.44, indicating a broad trading band. Support is cited at $124.96 and resistance at $135.75, suggesting a defined path for a potential move within a tight band over the next month. Annualized volatility stands at 30%, underscoring notable but not extreme swings over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $100.34 | $135.73 | $175.96 | 0% | Neutral | |
| $140.68 | $171.77 | $219.29 | +27% | Bullish | |
| $168.89 | $210.10 | $275.47 | +55% | Bullish | |
| $183.87 | $232.26 | $311.00 | +71% | Bullish | |
| $199.23 | $255.06 | $347.69 | +88% | Bullish | |
| $210.48 | $272.76 | $377.69 | +101% | Bullish | |
| $223.09 | $292.36 | $410.59 | +115% | Bullish | |
| $236.14 | $312.72 | $444.87 | +130% | Bullish | |
| $256.74 | $343.38 | $494.32 | +153% | Bullish | |
| $314.28 | $424.32 | $617.64 | +213% | Bullish | |
| $387.80 | $546.08 | $832.99 | +302% | Bullish | |
| $807.95 | $1,220.20 | $1,995.15 | +799% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $100.34 | $135.73 | $160.33 | +0.00% |
| August 2026 | $118.22 | $138.40 | $165.54 | +1.97% |
| September 2026 | $117.54 | $138.27 | $166.67 | -0.09% |
| October 2026 | $114.73 | $135.51 | $164.42 | -2.00% |
| November 2026 | $116.43 | $138.00 | $168.36 | +1.84% |
| December 2026 | $120.69 | $143.50 | $175.96 | +3.99% |
Click any year to see its month-by-month TFX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, TFX is projected to trade between $100.34 and $175.96, averaging $135.73 — a potential gain of 0% from today's $135.73. A consolidation phase looks the most probable path here.
Teleflex Incorporated's 2027 outlook centres on $171.77, within a $140.68 to $219.29 range. That is up +27% on the projected 2026 average. That marks a +27% change versus current levels. Momentum favours further upside here.
By 2028, TFX could reach as high as $275.47, with a base case around $210.10 and support toward $168.89 — roughly +55% from $135.73. Buyers look set to stay in control over this stretch.
Expect TFX to range from $183.87 to $311.00 through 2029. The $232.26 average target implies a +71% move from current prices. That is up +11% on the projected 2028 average. Momentum favours further upside here.
The TFX price prediction for 2030 points to an average of $255.06 (low $199.23, high $347.69) — a potential gain of +88% on today's $135.73. Buyers look set to stay in control over this stretch.
In 2031, TFX is projected to trade between $210.48 and $377.69, averaging $272.76 — a potential gain of +101% from today's $135.73. That is up +7% on the projected 2030 average. Momentum favours further upside here.
Teleflex Incorporated's 2032 outlook centres on $292.36, within a $223.09 to $410.59 range. That is up +7% on the projected 2031 average. That marks a +115% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, TFX could reach as high as $444.87, with a base case around $312.72 and support toward $236.14 — roughly +130% from $135.73. Momentum favours further upside here.
Expect TFX to range from $256.74 to $494.32 through 2034. The $343.38 average target implies a +153% move from current prices. That is up +10% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The TFX price prediction for 2035 points to an average of $424.32 (low $314.28, high $617.64) — a potential gain of +213% on today's $135.73. Momentum favours further upside here.
In 2040, TFX is projected to trade between $387.80 and $832.99, averaging $546.08 — a potential gain of +302% from today's $135.73. That is up +29% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Teleflex Incorporated's 2050 outlook centres on $1,220.20, within a $807.95 to $1,995.15 range. That is up +123% on the projected 2040 average. That marks a +799% change versus current levels. Momentum favours further upside here.
Investing $1,000 in TFX today (≈ 7.367568 TFX) could be worth
$8,989.9
+$7,989.9 (+799%) by 2050 · US Dollar
Based on the average projected TFX price of $1,220.2 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TFXwould be worth at today's price.
$1,000 invested in TFX on Jul 10, 2025 (≈ 8.337502 TFX) would be worth
$1,131.65
+$131.65 (+13.2%) today · 1.13× · US Dollar
Based on a TFX entry price of $119.94 vs. today's $135.73.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $133.99 | $1,012.99 | +1.3% |
| 1 month ago | $132.15 | $1,027.09 | +2.7% |
| 3 months ago | $118.39 | $1,146.47 | +14.6% |
| 6 months ago | $108.56 | $1,250.28 | +25.0% |
| 1 year ago | $119.94 | $1,131.65 | +13.2% |
| All time (5.0y) ago | $418.76 | $324.12 | -67.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TFX forecast.
Our base-case forecast reaches $270.00 around 2031.
Implied market cap at $270.00: $11.95B
The multi-year forecast lays out a clear ascent in average prices through 2030 and beyond, with markedly higher levels by 2040 and 2050. The 2026 forecast shows an average of $127.00 and a 2027 forecast of $164.23, followed by continued upside to 2030 at an average of $247.97 and a 95.3% ROI. By 2035 the average is $426.94 with a 236.2% ROI, and the bullish trend continues into 2040 with an average of $564.57 and a 344.5% ROI.
By 2050 the forecast projects an average of $1,266.05 and a 896.9% ROI, with a max price estimate of $2,070.76 in that year. Across the period, sentiments shift to bullish, signaling strong appetite for higher prices, while noting that these figures are estimates and not guarantees. The forecast envisions substantial upside driven by continued demand for medical devices, yet remains subject to market conditions and other real-world uncertainties.
Tap a question to reveal the answer.
The 2030 forecast shows an average of $247.97 with a min of $193.57 and a max of $338.32, and a 95.3% ROI; sentiment is bullish.
The forecast suggests significant upside, with 2026 average $127.00, rising to 2030 average $247.97 and 2050 average $1,266.05, and ROIs up to 896.9%; sentiment is bullish from 2027 onward.
Yes. The 2030 forecast lists a max of $338.32, with a min of $193.57 and an average of $247.97, and a 95.3% ROI; the sentiment is bullish.
The 2027 forecast shows an average of $164.23, a min of $134.36, and a max of $210.00, with a 29.3% ROI and bullish sentiment.
The 2040 forecast shows an average of $564.57, a min of $400.76, and a max of $861.56, with a 344.5% ROI and bullish sentiment.
Teleflex Incorporated Community Discussion
0Share your Teleflex Incorporated price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.